REMTHA Trademark

Trademark Overview

On Friday, November 9, 2012, a trademark application was filed for REMTHA with the United States Patent and Trademark Office. The USPTO has given the REMTHA trademark a serial number of 85775776. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 21, 2023. This trademark is owned by Glaxo Group Limited. The REMTHA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuitcal and medicinal preparations and substances; vaccines: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
remtha

General Information

Serial Number85775776
Word MarkREMTHA
Filing DateFriday, November 9, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 21, 2023
Registration Number5056993
Registration DateTuesday, October 11, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

Goods and ServicesPharmaceuitcal and medicinal preparations and substances; vaccines: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Friday, April 21, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 11, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, September 8, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, July 5, 2016NOTICE OF ALLOWANCE CANCELLED
Tuesday, May 31, 2016TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, January 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 19, 2016SOU EXTENSION 5 GRANTED
Monday, December 21, 2015SOU EXTENSION 5 FILED
Monday, December 21, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 16, 2015SOU EXTENSION 4 GRANTED
Monday, June 1, 2015SOU EXTENSION 4 FILED
Monday, June 15, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Wednesday, December 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 9, 2014SOU EXTENSION 3 GRANTED
Tuesday, December 2, 2014SOU EXTENSION 3 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Thursday, July 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 16, 2014SOU EXTENSION 2 GRANTED
Monday, June 23, 2014SOU EXTENSION 2 FILED
Tuesday, July 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Wednesday, December 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2013SOU EXTENSION 1 GRANTED
Monday, December 16, 2013SOU EXTENSION 1 FILED
Monday, December 16, 2013TEAS EXTENSION RECEIVED
Tuesday, July 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 29, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 26, 2013ASSIGNED TO LIE
Monday, March 11, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 11, 2013EXAMINER'S AMENDMENT ENTERED
Monday, March 11, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2013EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, March 7, 2013ASSIGNED TO EXAMINER
Friday, November 16, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 13, 2012NEW APPLICATION ENTERED

Related Keywords

remtha substances preparations treatment disorders pharmaceutical diseases vaccines hepatological ophthalmic oncological